Answers are grounded in this paper and cite their sources.
Sarcopenia is defined as the loss of skeletal muscle mass and strength that occurs with advancing age. This problem is increasingly being recognized in elderly adults.1 The European Wording Group on Sarcopenia in Older People (EWGSOP) proposed an algorithm for sarcopenia detection.2 Sarcopenia is considered to be characterized by a high risk of adverse health outcomes, including falls, fractures, functional decline, mortality, and low quality-of-life scores.2, 3 Previous population-based studies have shown that the prevalence of sarcopenia ranges between 8% and 50% in persons aged 50 and older, varying according to ethnicity, place of residence, age, and diagnostic method used.4-8 Taiwan is facing a great gerontological challenge because it has the fastest-aging population in the world, but no study has reported the prevalence of sarcopenia in Taiwan. This study aimed to determine the prevalence of sarcopenia using the EWGSOP algorithm in a general elderly population in a Taiwanese metropolitan area. A cross-sectional survey of a sample of 761 ethnic Taiwanese elderly adults aged 65 and older (range 65–98) who lived in eight administrative units of the North District of Taichung City, Taiwan, in 2009 was performed. Elderly adults with low muscle mass and low muscle strength or low physical performance were defined as having sarcopenia. Presarcopenia was defined as low muscle mass only and severe sarcopenia when the three conditions were present. Low muscle mass was determined according to the skeletal muscle mass index (appendicular skeletal muscle mass/height2). Skeletal muscle mass was measured using dual-energy X-ray absorptiometry (DXA; GE-LUNAR DPX PRO, Lunar Corporation, Madison, WI). Low muscle mass was defined as skeletal muscle mass index 2 standard deviations or more below the sex-specific means for young adults.9 Low muscle function was defined as grip strength in the lowest quintile at baseline measured using a handgrip dynamometer (TTM-110D, TTM Co., Tokyo, Japan) according to subgroups of sex and body mass index.10 Low physical performance was measured as the slowest quintile of the population according to subgroups of sex and standing height based on time needed to walk 15 feet.10 More than half of the participants were male, aged 65 to 74, and married, and had hypertension. The crude prevalence rates of presarcopenia, sarcopenia, and severe sarcopenia were 6.83%, 6.96%, and 6.04%, respectively. The age- and sex-weighted prevalence of sarcopenia (including severe sarcopenia) was 14.4% (range 13.0–15.7%). The age-specific prevalence rates of sarcopenia were 6.8%, 14.6%, and 41.7% in men aged 65 to 74, 75 to 84, and 85 and older, respectively, and 8.1%, 21.4%, and 26.7% in women aged 65 to 74, 75 to 84, and 85 and older. After considering the age, sex, marital status, regular exercise habits, comorbidity status (diabetes mellitus, stroke, heart disease, cataract, fall history), the following were found to be associated with greater prevalence of sarcopenia (Table 1): older age (odds ratio (OR) = 2.43, 95% confidence interval (CI) = 1.42–4.15 for 75–84; OR = 6.26, 95% CI = 2.75–14.25 for ≥85), no regular exercise (OR = 2.62, 95% CI = 1.61–4.26), and fall history (OR = 1.72, 95% CI = 1.03–2.90). The criteria proposed by EWGSOP were used to evaluate sarcopenia prevalence in an elderly noninstitutionalized civilian population of a metropolitan area in Taiwan. Sarcopenia was more common in older age groups, persons without regular exercise, and persons with a history of falls. These findings suggested that sarcopenia was prevalent in the elderly Taiwanese population and was thus a serious public health challenge in Taiwan metropolitan areas. A few surveys have been conducted on diverse community-dwelling populations to estimate sarcopenia prevalence.4-8 In general, the prevalence of sarcopenia in the current study was lower than the age-adjusted prevalence in the United States (15–25% for <70 and >40% for ≥80 in the New Mexico Elder Health Survey) and the sex-specific prevalence in Mexico (48.5% in women, 27.4% in men), closer to the crude prevalence in the Netherlands (15.7%), and higher than the crude prevalence in France (9.5%) and the sex-specific prevalence in the United States (7% for men and 10% for women in the National Health and Nutrition Examination Survey III). One reason for the divergent prevalence of sarcopenia is the methods of assessing muscle mass. Some of these studies used DXA,5, 7, 8 some used bioelectrical impedance,6 and the others used calf circumferences.4 In conclusion, sarcopenia was present in 14.4% of a Taiwanese population aged 65 and older in a metropolitan area. Substantial variations in the age, regular exercise status, and fall history were observed. Efforts such as exercise and treatment interventions for sarcopenia are needed to decrease the adverse effects in this elderly population. Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the authors and has determined that the authors have no financial or any other kind of personal conflicts with this paper. This study was supported by grants from the National Health Research Institutes of Taiwan (NHRI-EX98–9838PI), China Medical University (CMU98-S-11, CMU 99-S-27), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111–004).
No takes yet. Share an insight, caveat, or question.
Lin et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: